The Oncologic Implications of Tumor Multiplicity in Intrahepatic Cholangiocarcinoma: Its Prognostic Value Might Be Underestimated
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose In the latest staging system of the American Joint Committee on Cancer for intrahepatic cholangiocarcinoma (IHCCC), solitary tumors with vascular invasion and multiple tumors are grouped together as T2. However, recent studies report that multifocal IHCCC has a worse prognosis than a single lesion. This study aimed to investigate the risk factors for IHCCC and explore the prognostic significance of multiplicity after surgical resection. Materials and Methods A total of 257 patients underwent surgery for IHCCC from 2010 to 2019 and the clinicopathological data were retrospectively reviewed. Risk factor analysis was performed to identify variables associated with survival after resection. Survival outcomes were compared between patients with solitary and multiple tumors. Results In multivariable analysis, the presence of preoperative symptoms, tumor size, lymph node ratio, multiplicity, and tumor differentiation were identified as risk factors for survival. Among 82 patients with T2, overall survival was significantly longer in patients with solitary tumors (sT2) than in those with multiple tumors (mT2) (p=0.017). Survival was compared among patients with stage II-sT2, stage II-mT2, and stage III. The stage II-sT2 group showed prolonged survival when compared with stage II-mT2 or stage III. Survivals of stage II-mT2 and stage III patients were not statistically different. Conclusion Tumor multiplicity was an independent risk factor for overall survival of IHCCC after surgical resection. Patients with multiple tumors showed poorer survival than patients with a single tumor. The oncologic significance of multiplicity in IHCCC should be reappraised and reflected in the next staging system update.
Abstract
Purpose In the latest staging system of the American Joint Committee on Cancer for intrahepatic cholangiocarcinoma (IHCCC), solitary tumors with vascular invasion and multiple tumors are grouped together as T2. However, recent studies report that multifocal IHCCC has a worse prognosis than a single lesion. This study aimed to investigate the risk factors for IHCCC and explore the prognostic significance of multiplicity after surgical resection. Materials and Methods A total of 257 patients underwent surgery for IHCCC from 2010 to 2019 and the clinicopathological data were retrospectively reviewed. Risk factor analysis was performed to identify variables associated with survival after resection. Survival outcomes were compared between patients with solitary and multiple tumors. Results In multivariable analysis, the presence of preoperative symptoms, tumor size, lymph node ratio, multiplicity, and tumor differentiation were identified as risk factors for survival. Among 82 patients with T2, overall survival was significantly longer in patients with solitary tumors (sT2) than in those with multiple tumors (mT2) (p=0.017). Survival was compared among patients with stage II-sT2, stage II-mT2, and stage III. The stage II-sT2 group showed prolonged survival when compared with stage II-mT2 or stage III. Survivals of stage II-mT2 and stage III patients were not statistically different. Conclusion Tumor multiplicity was an independent risk factor for overall survival of IHCCC after surgical resection. Patients with multiple tumors showed poorer survival than patients with a single tumor. The oncologic significance of multiplicity in IHCCC should be reappraised and reflected in the next staging system update.
참고문헌 (31)
- Khan SA, "Cholangiocarcinoma : epidemiology and risk factors", Liver Int, 39(Suppl 1), pp.19~31 (2019)
- Lee AJ, "Intrahepatic cholangiocarcinoma : the AJCC", UICC 8th edition updates, 2018, pp.7, 52~
- Amin MB, "AJCC cancer staging manual" (2018), Springer International Publishing
- Chen Y, "Reappraisal of the T category for solitary intrahepatic cholangiocarcinoma by tumor size in 611 early-stage(T1-2N0M0)patients after hepatectomy : a Surveillance, Epidemiology, and End Results(SEER)analysis", J Gastrointest Surg, 25, pp.1989~1999 (2021)
- Turner KM, "A national assessment of T2 staging for intrahepatic cholangiocarcinoma and the poor prognosis associated with multifocality", Ann Surg Oncol, 29, pp.5094~5102 (2022)
- Conci S, "Patterns of distribution of hepatic nodules(single, satellites or multifocal)in intrahepatic cholangiocarcinoma : prognostic impact after surgery", Ann Surg Oncol, 25, pp.3719~3727 (2018)
- Edge SB, "AJCC cancer staging manual" (2009), Springer
- Lamarca A, "Liver metastases of intrahepatic cholangiocarcinoma : implications for an updated staging system", Hepatology, 73, pp.2311~2325 (2021)
- Yamamoto Y, "The evaluation of the eighth edition of the AJCC", UICC staging system for intrahepatic cholangiocarcinoma : a proposal of a modified new staging system, 2020, pp.24, 786~795
- Wright GP, "Surgical resection does not improve survival in multifocal intrahepatic cholangiocarcinoma : a comparison of surgical resection with intra-arterial therapies", Ann Surg Oncol, 25, pp.83~90 (2018)
- Weber SM, "Intrahepatic cholangiocarcinoma : expert consensus statement", HPB(Oxford), 17, pp.669~680 (2015)
- Li J, "ALPPS for locally advanced intrahepatic cholangiocarcinoma: did aggressive surgery lead to the oncological benefit? An international multi-center study", Ann Surg Oncol, 27, pp.1372~1384 (2020)
- Uenishi T, "Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases", J Hepatobiliary Pancreat Surg, 15, pp.417~422 (2008)
- Lamarca A, "Advanced intrahepatic cholangiocarcinoma : post hoc analysis of the ABC-01, -02, and-03 clinical trials", J Natl Cancer Inst, 112, pp.200~210 (2020)
- Conci S, "Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers", Cancers(Basel), 13, pp.3594~ (2021)
- Yoon SJ, "Development of nomograms for predicting prognosis of pancreatic cancer after pancreatectomy : a multicenter study", Biomedicines, 10, pp.1341~ (2022)
- Miyahara Y, "The prognostic impact of neutrophil-to-lymphocyte ratio(NLR)and lymphocyte-to-monocyte ratio(LMR)in patients with distal bile duct cancer", World J Surg Oncol, 18, pp.78~ (2020)
- Steele CW, "Exploiting inflammation for therapeutic gain in pancreatic cancer", Br J Cancer, 108, pp.997~1003 (2013)
- Kusumanto YH, "Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor", Angiogenesis, 6, pp.283~287 (2003)
- Sellers CM, "Inflammatory markers in intrahepatic cholangiocarcinoma : effects of advanced liver disease", Cancer Med, 8, pp.5916~5929 (2019)
- Tsilimigras DI, "The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma : an international multi-institutional analysis", HPB(Oxford), 22, pp.1667~1674 (2020)
- Noguchi D, "The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma : a comparative study of major representative inflammatory", immunonutritional markers, 2021, pp.16, e0245946~
- Tsilimigras DI, "Development and validation of a Laboratory Risk Score(LabScore)to predict outcomes after resection for intrahepatic cholangiocarcinoma", J Am Coll Surg, 230, pp.381~391 (2020)
- Jutric Z, "Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy : a review of the National Cancer Database", HPB(Oxford), 18, pp.79~87 (2016)
- Zhang XF, "Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent", Br J Surg, 105, pp.848~856 (2018)
- Cillo U, "Surgery for cholangiocarcinoma", Liver Int, 39(Suppl 1), pp.143~155 (2019)
- Hu H, "The role of lymph node dissection in intrahepatic cholangiocarcinoma : a multicenter retrospective study", BMC Surg, 21, pp.359~ (2021)
- Kim SH, "Extent of lymph node dissection for accurate staging in intrahepatic cholangiocarcinoma", J Gastrointest Surg, 26, pp.70~76 (2022)
- Ruzzenente A, "Role of lymph node dissection in small(≤ 3 cm)intrahepatic cholangiocarcinoma", J Gastrointest Surg, 23, pp.1122~1129 (2019)
- Nakagawa T, "Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma", World J Surg, 29, pp.728~733 (2005)
- Sahara K, "Therapeutic index associated with lymphadenectomy among patients with intrahepatic cholangiocarcinoma : which patients benefit the most from nodal evaluation?", Ann Surg Oncol, 26, pp.2959~2968 (2019)